Treatment Research Service is categorized under Commercial Medical Research in Lancaster, PA and active since 1998.
Treatment Research Service was established in 1998, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6213400 by the NAICS.
If you are seeking more information, feel free to contact Paul West, Owner at the company’s single location by writing to 641 Wyncroft Lane Apartment 3, Lancaster, Pennsylvania PA 17603 or by phoning (717) 290-1430. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Treatment Research Service |
| Contact Person: | Paul West, Owner |
| Address: | 641 Wyncroft Lane Apartment 3, Lancaster, Pennsylvania 17603 |
| Phone Number: | (717) 290-1430 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1998 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6213400 |
| Share This Business: |
Treatment Research Service was started in 1998 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6213400. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Paul West, Owner for inquiries that concern Treatment Research Service by calling the company number (717) 290-1430, as your correspondence is most welcome. Additionally, the physical location of the single location of Treatment Research Service can be found at the coordinates 40.016747,-76.31743 as well as the street address 641 Wyncroft Lane Apartment 3 in Lancaster, Pennsylvania 17603.
For its online presence, you may visit Treatment Research Service’s website at and engage with its social media outlets through on Twitter and on Facebook.